{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:36:08Z","timestamp":1776681368118,"version":"3.51.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1990,1]]},"DOI":"10.1007\/bf01857634","type":"journal-article","created":{"date-parts":[[2005,6,30]],"date-time":"2005-06-30T22:57:13Z","timestamp":1120172233000},"page":"199-206","source":"Crossref","is-referenced-by-count":39,"title":["Angiotensin converting enzyme inhibitors: Comparative structure, pharmacokinetics, and pharmacodynamics"],"prefix":"10.1007","volume":"4","author":[{"given":"Gurdarshan S.","family":"Thind","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01857634_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.59.3.347","volume":"49","author":"HJ Goldblatt","year":"1934","unstructured":"Goldblatt HJ, Lynch RF, Hanzal RF, et al. Studies on experimental hypertension: Production of persistent elevation of systolic blood pressure by means of renal ischemia.J Exp Med 1934;49:347\u2013379.","journal-title":"J Exp Med"},{"key":"BF01857634_CR2","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1021\/bi00798a004","volume":"10","author":"MA Ondetti","year":"1971","unstructured":"Ondetti MA, Williams NJ, Sabo EF, et al. Angiotensin converting enzyme inhibitors from the venom ofBathrops jararaca: Isolation, elucidation of structure and synthesis.Biochemistry 1971;10:4033\u20134039.","journal-title":"Biochemistry"},{"key":"BF01857634_CR3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.191908","volume":"196","author":"MA Ondetti","year":"1977","unstructured":"Ondetti MA, Rubin B, Cushman DW. Design of specific inhibitors of angiotensin converting enzyme: New class of orally active antihypertensive agents.Science 1977;196:441\u2013444.","journal-title":"Science"},{"key":"BF01857634_CR4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/bi00644a014","volume":"16","author":"DW Cushman","year":"1977","unstructured":"Cushman DW, Cheung HS, Sabo EF, et al. Design of potent competitive inhibitors of angiotensin converting enzyme: Carboxyalkanoyl and mercaptoalkanoyl amino acids.Biochemistry 1977;16:548\u2013591.","journal-title":"Biochemistry"},{"key":"BF01857634_CR5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/288280a0","volume":"288","author":"AA Patchett","year":"1980","unstructured":"Patchett AA, Harris E, Tristran EW, et al. A new class of angiotensin-converting enzyme inhibitors.Nature 1980;288: 280\u2013283.","journal-title":"Nature"},{"key":"BF01857634_CR6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.103.3.295","volume":"103","author":"LT Skeggs","year":"1956","unstructured":"Skeggs LT, Kahn JR, Shumway NP. The preparation and function of the hypertension converting enzyme.J Exp Med 1956;103:295\u2013299.","journal-title":"J Exp Med"},{"key":"BF01857634_CR7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/med.2610050405","volume":"5","author":"MJ Wyvrat","year":"1985","unstructured":"Wyvrat MJ, Patchett AA. Recent developments in the design of angiotensin-converting enzyme inhibitors.Med Res Rev 1985;5:483\u2013531.","journal-title":"Med Res Rev"},{"issue":"283","key":"BF01857634_CR8","first-page":"235","volume":"9","author":"EW Petrillo","year":"1987","unstructured":"Petrillo EW, Powell JR, Cushman DW, et al. Angiotensin converting enzyme inhibitors: Accomplishments and challenges.Clin Exp Hypertens 1987;A9(283):235\u2013241.","journal-title":"Clin Exp Hypertens"},{"key":"BF01857634_CR9","unstructured":"Karanewsky DS, Badia MC, Cushman DW, et al. Novel orally active inhibitors of angiotensin-converting enzyme.Proc 192nd ACS Natl Meeting 1986, Abst Medi 8."},{"key":"BF01857634_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/ajh\/2.1.57","volume":"2","author":"JB Kostis","year":"1989","unstructured":"Kostis JB. Angiotensin-converting enzyme inhibitors: Emerging differences and new compounds.Am J Hypertens 1989;2:57\u201364.","journal-title":"Am J Hypertens"},{"issue":"Suppl I","key":"BF01857634_CR11","first-page":"14","volume":"77","author":"VJ Dzau","year":"1988","unstructured":"Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.Circulation 1988;77 (Suppl I):14\u2013113.","journal-title":"Circulation"},{"key":"BF01857634_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI112768","volume":"79","author":"DJ Campbell","year":"1987","unstructured":"Campbell DJ. Circulating and tissue angiotensin systems.J Clin Invest 1987;79:1\u20136.","journal-title":"J Clin Invest"},{"key":"BF01857634_CR13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1172\/JCI113142","volume":"80","author":"SK Wilson","year":"1987","unstructured":"Wilson SK, Lynch DR, Snyder SH. Angiotensin-converting enzyme labeled with [3H] captopril.J Clin Invest 1987; 80:841\u2013850.","journal-title":"J Clin Invest"},{"key":"BF01857634_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.RES.31.1.36","volume":"31","author":"JC McGiff","year":"1972","unstructured":"McGiff JC, Terragno NA, Malik KU, et al. Release of prostaglandin E-like substance from canine kidney by bradykinin.Circ Res 1972;31:36\u201343.","journal-title":"Circ Res"},{"key":"BF01857634_CR15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2165\/00003495-198836050-00003","volume":"36","author":"RN Brogden","year":"1988","unstructured":"Brogden RN, Todd PA, Sorkin EM. Captopril, an, update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure.Drugs 1988;36:540\u2013600.","journal-title":"Drugs"},{"key":"BF01857634_CR16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0002-9149(82)90351-4","volume":"49","author":"SL Swartz","year":"1982","unstructured":"Swartz SL, Williams GH. Angiotensin-converting enzyme inhibition and prostaglandins.Am J Cardiol 1982;49:1405\u20131409.","journal-title":"Am J Cardiol"},{"key":"BF01857634_CR17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0002-8703(83)90286-7","volume":"105","author":"S Mookherjee","year":"1983","unstructured":"Mookherjee S, Anderson GH, Eich R, et al. Acute effects of captopril on cardiopulmonary hemodynamics and reninangiotensin-aldosterone and bradykinin profile in hypertension.Am Heart J 1983;105:106\u2013112.","journal-title":"Am Heart J"},{"key":"BF01857634_CR18","first-page":"587","volume":"9","author":"H Nishimura","year":"1987","unstructured":"Nishimura H, Kubo S, Ueyama M, et al. Effects of captopril on peripheral hemodynamics in severe congestive heart failure.Clin Exp Hypertens 1987;A9:587\u2013591.","journal-title":"Clin Exp Hypertens"},{"key":"BF01857634_CR19","doi-asserted-by":"crossref","first-page":"261S","DOI":"10.1042\/cs063261s","volume":"63","author":"A Salvetti","year":"1982","unstructured":"Salvetti A, Pedrinelli R, Magagna A, et al. Differential effects of selective and non-selective prostaglandin-synthesis inhibition on the pharmacological responses to captopril patients with essential hypertension.Clin Science 1982; 63:261S\u2013263S.","journal-title":"Clin Science"},{"issue":"Suppl 1","key":"BF01857634_CR20","first-page":"53","volume":"1","author":"CS Sweet","year":"1983","unstructured":"Sweet CS, Gaul SL, Reitz AM, et al. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.J Hypertens 1983;1 (Suppl 1):53\u201363.","journal-title":"J Hypertens"},{"key":"BF01857634_CR21","first-page":"538","volume":"31","author":"S Oparil","year":"1983","unstructured":"Oparil S, Horton R, Wilkins LH, et al. Antihypertensive effect of enalapril (MK-421) in low renin essential hypertension: Role of Vasodilator prostaglandins. (abstract).Clin Res 1983;31:538A.","journal-title":"Clin Res"},{"key":"BF01857634_CR22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003495-198631030-00002","volume":"31","author":"PA Todd","year":"1986","unstructured":"Todd PA, Heel RC. Enalapril, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure.Drugs 1986; 31:198\u2013248.","journal-title":"Drugs"},{"key":"BF01857634_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/j.1552-4604.1982.tb02661.x","volume":"22","author":"SM Singhvi","year":"1982","unstructured":"Singhvi SM, McKinstry DN, Shaw JM, et al. Effect of food on the bioavailability of captopril in healthy subjects.J Clin Pharmacol 1982;22:135\u2013140.","journal-title":"J Clin Pharmacol"},{"key":"BF01857634_CR24","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/jps.2600731146","volume":"73","author":"BN Swansons","year":"1984","unstructured":"Swansons BN, Vlasses PH, Ferguson RK, et al. Influence of food on the bioavailability of enalapril.J Pharm, Sci 1984; 73:1655\u20131657.","journal-title":"J Pharm, Sci"},{"key":"BF01857634_CR25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/bmj.293.6545.467","volume":"293","author":"E Hommel","year":"1986","unstructured":"Hommel E, Hans-Henrik P, Mathiesen E, et al. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.Br Med J 1986;293:467\u2013470.","journal-title":"Br Med J"},{"key":"BF01857634_CR26","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/bmj.294.6585.1448","volume":"294","author":"M Marre","year":"1987","unstructured":"Marre M, Leblanc H, Suarez L, et al. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.Br Med J 1987; 294:1448\u20131452.","journal-title":"Br Med J"},{"key":"BF01857634_CR27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2165\/00003495-198835060-00003","volume":"35","author":"SG Lancester","year":"1988","unstructured":"Lancester SG, Todd PA. Lisinopril, a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure.Drugs 1988;35:646\u2013669.","journal-title":"Drugs"},{"key":"BF01857634_CR28","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/03602538409041080","volume":"15","author":"BH Migdalof","year":"1984","unstructured":"Migdalof BH, Antonaccio MJ, McKinstry DN, et al. Captopril: Pharmacology, metabolism and disposition.Drug Metab Rev 1984;15:841\u2013869.","journal-title":"Drug Metab Rev"},{"issue":"Suppl 1","key":"BF01857634_CR29","first-page":"130","volume":"77","author":"W Westlin","year":"1988","unstructured":"Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?Circulation 1988;77 (Suppl 1):130\u2013139.","journal-title":"Circulation"},{"key":"BF01857634_CR30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0167-5273(86)90197-X","volume":"11","author":"HJ Gomez","year":"1986","unstructured":"Gomez HJ, Cieillo VJ, Davis RO, et al. Enalapril in congestive heart failure: Acute and chronic invasive hemodynamic evaluation.Int J Cardiol 1986;11:37\u201348.","journal-title":"Int J Cardiol"},{"key":"BF01857634_CR31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM198302173080709","volume":"308","author":"WB Blythe","year":"1983","unstructured":"Blythe WB. Captopril and renal autoregulation.N Engl J Med 1983;308:390\u2013391.","journal-title":"N Engl J Med"},{"key":"BF01857634_CR32","first-page":"337","volume":"4","author":"GS Thind","year":"1985","unstructured":"Thind GS. Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.J Clin Hypertens 1985;4:337\u2013343.","journal-title":"J Clin Hypertens"},{"key":"BF01857634_CR33","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/archinte.1987.00370080033008","volume":"147","author":"JH Bauer","year":"1987","unstructured":"Bauer JH, Reams GP, Lal SM. Renal protective effect of strict blood pressure control with enalapril therapy.Arch Intern Med 1987;147:1397\u20131400.","journal-title":"Arch Intern Med"},{"key":"BF01857634_CR34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI112013","volume":"76","author":"S Anderson","year":"1985","unstructured":"Anderson S, Meyer TW, Renke HG, et al. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.J Clin Invest 1985;76:612\u2013619.","journal-title":"J Clin Invest"},{"key":"BF01857634_CR35","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1172\/JCI112521","volume":"77","author":"R Zatz","year":"1986","unstructured":"Zatz R, Dunn BR, Meyer TW, et al. Prevention of diabetic glomerularopathy by pharmacological amelioration of glomerular capillary hypertension.J Clin Invest 1986;77:1925\u20131930.","journal-title":"J Clin Invest"},{"key":"BF01857634_CR36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0002-9343(86)90718-7","volume":"80","author":"S Anderson","year":"1986","unstructured":"Anderson S, Brenner BM. Effects of aging on the renal glomerulus.Am J Med 1986;80:435\u2013442.","journal-title":"Am J Med"},{"key":"BF01857634_CR37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(85)90078-6","volume":"79","author":"L Raij","year":"1985","unstructured":"Raij L, Chiou X, Owens R, et al. Therapeutic implications of hypertension-induced glomerular injury.Am J Med 1985; 79:37\u201341.","journal-title":"Am J Med"},{"key":"BF01857634_CR38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0272-6386(84)80027-X","volume":"4","author":"JH Bauer","year":"1984","unstructured":"Bauer JH, Jones LB. Comparative studies: Enalapril versus hydrochlorothiazide a first-step therapy for the treatment of primary hypertension.Am J Kidney Dis 1984;4:55\u201362.","journal-title":"Am J Kidney Dis"},{"key":"BF01857634_CR39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/BF01725707","volume":"62","author":"W Vetter","year":"1984","unstructured":"Vetter W, Wehling M, Foerster ECh, et al. Long-term effect of captopril on kidney function in various forms of hypertension.Klin Wochenschr 1984;62:731\u2013737.","journal-title":"Klin Wochenschr"},{"key":"BF01857634_CR40","first-page":"710","volume":"38","author":"G Venuto De","year":"1985","unstructured":"De Venuto G, Andreotti C, Mattarei M, et al. Prolonged treatment of essential hypertension and renal function: Comparison of captopril and beta-blockers considering microproteinuria values.Curr Ther Res 1985;38:710\u2013718.","journal-title":"Curr Ther Res"},{"issue":"Suppl I","key":"BF01857634_CR41","first-page":"174","volume":"77","author":"MA Ondetti","year":"1988","unstructured":"Ondetti MA. Structure relationship of angiotensin converting enzyme inhibitors ot pharmacologic activity.Circulation 1988;77 (Suppl I):174\u2013178.","journal-title":"Circulation"},{"key":"BF01857634_CR42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ki.1984.119","volume":"25","author":"RM Zussman","year":"1984","unstructured":"Zussman RM. Renin and nonrenin mediated antihypertensive action of converting enzyme inhibitors.Kidney Int 1984;25:969\u2013983.","journal-title":"Kidney Int"},{"key":"BF01857634_CR43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0002-9343(86)90722-9","volume":"80","author":"IA Jaffe","year":"1986","unstructured":"Jaffe IA. Adverse effects profile of sulfhydryl compounds in man.Am J Med 1986;80:471\u2013476.","journal-title":"Am J Med"},{"key":"BF01857634_CR44","doi-asserted-by":"crossref","first-page":"227S","DOI":"10.1093\/ajh\/1.3.227S","volume":"1","author":"GS Thind","year":"1988","unstructured":"Thind GS. Demography predicts blood pressure response to once-daily enalapril monotherapy of mild-to-moderate essential hypertensive patients.Am J Hypertens 1988;1:227S\u2013229S.","journal-title":"Am J Hypertens"},{"issue":"Suppl 5","key":"BF01857634_CR45","first-page":"S423","volume":"4","author":"GS Thind","year":"1986","unstructured":"Thind GS. Lisinopril versus atenolol alone and with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.J Hypertens 1986;4 (Suppl 5):S423\u2013S425.","journal-title":"J Hypertens"},{"key":"BF01857634_CR46","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0002-8703(85)90650-7","volume":"109","author":"GS Thind","year":"1985","unstructured":"Thind GS, Johnson A, Bhatnagar D, et al. A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension.Am Heart J 1985;109:852\u2013858.","journal-title":"Am Heart J"},{"key":"BF01857634_CR47","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.CIR.67.6.1340","volume":"67","author":"GS Thind","year":"1983","unstructured":"Thind GS, Mahapatra RK, Johnson A, et al. Low-dose captopril titration in patients with moderate-to-severe hypertension treated with diuretics.Circulation 1983;67:1340\u20131346.","journal-title":"Circulation"},{"key":"BF01857634_CR48","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"The Concensus Trial Study Group","year":"1987","unstructured":"The Concensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure.N Engl J Med 1987;316:1429\u20131435.","journal-title":"N Engl J Med"},{"key":"BF01857634_CR49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00003495-198937020-00004","volume":"37","author":"PA Todd","year":"1989","unstructured":"Todd PA, Goa KL. Enalapril: An update on its pharmacological properties and therapuetic use in congestive heart failure.Drugs 1989;37:141\u2013161.","journal-title":"Drugs"},{"key":"BF01857634_CR50","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM198610023151402","volume":"315","author":"M Packer","year":"1986","unstructured":"Packer M, Lee WH, Yashak M, et al. Comparison of captopril and enalapril in patients with severe chronic heart failure.N Engl J Med 1986;315:847\u2013853.","journal-title":"N Engl J Med"},{"key":"BF01857634_CR51","unstructured":"Abramowicz M (ed). ACE inhibitors for congestive heart failure.Med Lett 1988;30:97\u201398."},{"key":"BF01857634_CR52","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0002-9149(88)90549-8","volume":"62","author":"J Rutledge","year":"1988","unstructured":"Rutledge J, Ayers C, Davidson R, et al. Effect of intravenous enalaprilat in moderate and severe systemic hypertension.Am J Cardiol 1988;62:1062\u20131067.","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01857634.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01857634\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01857634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:25:21Z","timestamp":1557483921000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01857634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["BF01857634"],"URL":"https:\/\/doi.org\/10.1007\/bf01857634","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,1]]}}}